NCT04089995

Brief Summary

Coats plus syndrome is a very rare and serious disease, caused by premature telomere shortening. It is a pediatric, multi-systemic disease, the main features of which are retinal vasculopathy and neurological disorders, associated with brain calcification and leukodystrophy. Its precise genetic etiology was discovered in 2012: autosomal recessive mutation of the CTC1 gene. Publications about this syndrome are very few, and consist only of case reports, or small series of cases. This is explained by the rarity of occurrence of this syndrome. Since 1988, 57 cases of Coats plus syndrome have been published, with case series of up to 13 patients. Only 28 cases were detailed concerning the precise clinical presentation in the literature. The general characteristics of this syndrome are known and, in addition to the ophthalmological and neurological damage, the various publications have been able to report a digestive attack (hemorrhages), hematological damage (central cytopenias), or increased bone fragility. No treatment is currently available to cure patients. The natural history of this disease is poorly known. However, the most accurate knowledge possible of this disease, and its natural history, is essential. It would allow an easier identification of this rare syndrome, the establishment of a management (monitoring and therapeutic) adapted, and a more accurate genetic counseling in case of need of a prenatal diagnosis. The description of a new series of unpublished cases, as well as a comprehensive review of the literature on Coats plus syndrome, will provide a more comprehensive and informed view of this disease. Moreover, LCC syndrome (leukoencephalopathy with calcifications and cysts) is an autosomal recessive disorder linked to a mutation in the SNORD118 gene, which has the particularity of presenting the same neurological (neuro-radiological and clinical) characteristics, but without associating the others. ophthalmological and systemic disorders. It constitutes the differential radiological diagnosis of Coats plus syndrome. In this, the collection of medical data of French pediatric cases presenting this syndrome will allow a more detailed analysis of the differences and similarities between these two syndromes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2019

Shorter than P25 for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 16, 2019

Completed
14 days until next milestone

Study Start

First participant enrolled

September 30, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

March 17, 2020

Status Verified

March 1, 2020

Enrollment Period

3 months

First QC Date

July 16, 2019

Last Update Submit

March 16, 2020

Conditions

Keywords

Coatsleukencephalopathy with calcifications and cysts

Outcome Measures

Primary Outcomes (10)

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with neurological complication : seizures Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with neurological complication : focal clinical abnormality Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with neurological complication : cognitive trouble. Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with abnormal brain imaging : exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with digestive complication : bleeding Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with digestive complication :hepatic disease Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    percentage of patients with bone complication : osteoporosis Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    Percentage of patients with ophthalmologic complication : Coats disease Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    Percentage of patients with hair or nails abnormality Exploratory description for each patient

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome

    Percentage of patients with intra uterine growth retardation or neonatal trouble : exploratory description for each patient Any disease or complication in the medical history

    through study completion, an average of 1 year

Secondary Outcomes (12)

  • Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome

    through study completion, an average of 1 year

  • Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome

    through study completion, an average of 1 year

  • +7 more secondary outcomes

Study Arms (1)

Coats + and LCC syndrome

Other: data collection

Interventions

No intervention

Coats + and LCC syndrome

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with Coats plus genetic and / or clinical Syndrome, pediatric onset and Patients with genetic and / or clinical LCC syndrome, pediatric onset

You may qualify if:

  • Patient with Coats plus genetic and / or clinical Syndrome, pediatric onset
  • Patients with genetic and / or clinical LCC syndrome, pediatric onset

You may not qualify if:

  • Refusal of the patient or his family (oral opposition)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Hopital Kremlin Bicêtre

Le Kremlin-Bicêtre, 94270, France

Location

CHU de Limoges

Limoges, 87042, France

Location

Hospices civils de Lyon

Lyon, 69004, France

Location

Fondation Adolphe de ROTHSCHILD

Paris, 75019, France

Location

Hopital Robert Debré

Paris, 75019, France

Location

CHU de Rennes

Rennes, 35033, France

Location

MeSH Terms

Conditions

Retinal TelangiectasisCysts

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesTelangiectasisVascular DiseasesCardiovascular DiseasesNeoplasmsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2019

First Posted

September 16, 2019

Study Start

September 30, 2019

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

March 17, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations